C World Wide Group Holding A Neurocrine Biosciences Inc Transaction History
C World Wide Group Holding A
- $8.2 Billion
- Q4 2024
A detailed history of C World Wide Group Holding A transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, C World Wide Group Holding A holds 115,000 shares of NBIX stock, worth $13.2 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
115,000
Previous 95,000
21.05%
Holding current value
$13.2 Million
Previous $10.9 Million
43.41%
% of portfolio
0.19%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
95.2MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.16 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$560 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$345 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$290 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...